Do We Really Need to Predict Paravalvular Regurgitation After TAVI With Aortic Valve Calcium Load Before the Procedure?

J Cardiovasc Imaging

Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

Published: October 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592248PMC
http://dx.doi.org/10.4250/jcvi.2022.0075DOI Listing

Publication Analysis

Top Keywords

predict paravalvular
4
paravalvular regurgitation
4
regurgitation tavi
4
tavi aortic
4
aortic valve
4
valve calcium
4
calcium load
4
load procedure?
4
predict
1
regurgitation
1

Similar Publications

Objective: Minimally invasive aortic valve replacement (MIAVR) and transcatheter aortic valve replacement (TAVR) represent less-invasive alternatives to conventional surgical aortic valve replacement. In contrast to Society of Thoracic Surgeons (STS) Database data revealing <10% of all surgical aortic valve replacement procedures are performed via a minimally invasive approach, our center performs a high volume of MIAVR procedures. This propensity-score matched study aims to compare the outcomes of MIAVR versus TAVR in low-risk patients (STS Predicted Risk of Mortality <4%).

View Article and Find Full Text PDF

A Comparison of Short-Term Clinical Outcomes Between the Navitor and Evolut Transcatheter Aortic Valve Prostheses.

J Clin Med

August 2025

Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, 80636 Munich, Germany.

The novel Navitor intra-annular self-expandable transcatheter aortic valve prosthesis is designed to improve coronary access, reduce paravalvular leaks, and enhance hemodynamic performance. Comparative data with the established Evolut platform (R, Pro, FX) are still lacking. This study aimed to evaluate the short-term clinical outcomes of Navitor (NAV) versus Evolut transcatheter heart valves.

View Article and Find Full Text PDF

Background: Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of severe aortic valve stenosis (AS). Balloon post-dilatation (PD) remains an important procedural step to optimize valve function by resolving incomplete valve expansion, which may lead to paravalvular regurgitation and other potentially adverse effects. There are only limited data on the predictors, incidence, and clinical impact of PD during TAVI.

View Article and Find Full Text PDF

Background: Transcatheter pulmonary valve replacement (TPVR) has emerged as a less invasive alternative to surgical pulmonary valve replacement for patients with right ventricular outflow tract (RVOT) dysfunction, such is especially important for those individuals whom had previous cardiac surgical procedures. Recently, three-dimensional (3D) printing and finite element (FE) computational simulation technologies have been employed to enhance preoperative planning processes; however, their effectiveness and clinical significance remain to be fully validated. This systematic review aims to describe the applications and potential impacts of 3D printing and FE simulation technologies for TPVR in clinical practice.

View Article and Find Full Text PDF

Evidence suggests that even mild-to-moderate paravalvular regurgitation (PVR) following transcatheter aortic valve implantation (TAVI) is associated with adverse outcomes. We directly compared the diagnostic performance and predictive value of invasive (hemodynamic) versus noninvasive (echocardiographic) assessments of PVR. Additionally, we explored the effectiveness of a comprehensive integrated approach that combines both methodologies to accurately identify and predict the clinical consequences of PVR.

View Article and Find Full Text PDF